OptimizeRx Corp (OPRX) stock
Close on Nov 11, 2026Market cap $168.58MP/E 37.3Yield –
OptimizeRx Corp saw revenue fall 5.8% to $98.65M over the twelve months to Jun 30, 2026. Free cash flow was $18.36M, up 77.5% from a year earlier. At the latest close the market valued the company at $168.58M, 37.3 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $168.58M
- P/E ratio
- 37.3
- Price to sales
- 1.71
- Price to book
- 1.29
- Dividend yield
- –
- Free cash flow yield
- 10.89%
Fundamentals
- Revenue
- $98.65M
- Net income
- $4.60M
- EPS, diluted
- $0.24
- Free cash flow
- $18.36M
- Book value per share
- $6.98
- Diluted shares
- 19M
Trading
- Next earnings
- Q3 FY2026, expected soon
- Previous close
- $9.35
- Open
- $9.40
- Day's range
- $8.85 – $9.83
- Volume
- 389,785
- Average volume (20 days)
- 151,809
- Beta (5 years)
- 1.97
- 52-week range
- $4.54 – $16.84
- RSI (14 days)
- 50.4
- Volatility (1 year)
- 68.6%
- Relative volume
- 2.01×
- WACC
- 14.3%
Market cap history
Month-end market cap since 2013, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | OPRX | S&P 500 | Difference | OPRX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +8.1% | -2.4% | +10.5 pts | ||
| 3 months | +29.3% | -1.2% | +30.5 pts | ||
| Year to date | -27.0% | +12.3% | −39.3 pts | ||
| 1 year | -43.7% | +12.4% | −56.1 pts | ||
| 3 years | -1.9% | +78.8% | −80.7 pts | -0.6% | +21.4% |
| 5 years | -89.2% | +75.2% | −164.3 pts | -35.9% | +11.9% |
| 10 years | +204.4% | +311.1% | −106.7 pts | +11.8% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases OptimizeRx filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
About OptimizeRx
Services-Business Services, NEC
OptimizeRx Corporation provides digital healthcare technology and marketing solutions for the life sciences sector. The company offers technology platforms that enable pharmaceutical manufacturers and marketing agencies to reach healthcare professionals and patients. Its core solutions include an artificial intelligence-driven Dynamic Audience Activation Platform, patent-protected Micro-Neighborhood Targeting, and audience profiling tools. It also delivers banner messaging through point-of-care networks, real-time pharmacy dispensing alerts, and financial copay messaging integrated directly into electronic health record systems and electronic prescribing platforms.
Company profile, executives and historyOptimizeRx stock: common questions
What is OptimizeRx's stock price?
OPRX closed at $8.95 on Nov 11, 2026, down 4.28% on the day. Over the past 52 weeks it traded between $4.54 and $16.84.
What is OptimizeRx's market cap?
OptimizeRx was worth $168.58M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is OPRX's P/E ratio?
OPRX trades at 37.3 times earnings, based on diluted earnings per share of $0.24 over the twelve months to Jun 30, 2026.
How much revenue does OptimizeRx make?
OptimizeRx reported revenue of $98.65M for the twelve months to Jun 30, 2026, down 5.8% from a year earlier.
Does OptimizeRx pay a dividend?
No. OptimizeRx has not paid a cash dividend over the last twelve months.
When does OptimizeRx report earnings next?
OptimizeRx's Q3 FY2026 results are due soon; the company has not yet filed them with the SEC.
How has OPRX stock performed over the past year?
Including dividends, OPRX returned -43.7% over the past year, against +12.4% for the S&P 500.
How many OPRX shares are sold short?
1M shares were sold short at the latest FINRA report, 7.82% of the float, or 9.8 days of average trading volume.
Who are OptimizeRx's competitors?
Companies most similar to OptimizeRx by business, industry and size include AMWL, DHX, PHR, PAYS, RSSS.
See a number that looks wrong?